Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.37 |
| ▸ | ALB | P02768 | 1/20 | 0.35 |
| ▸ | CCKAR | P32238 | 6/20 | 0.35 |
| ▸ | CCKBR | P32239 | 6/20 | 0.35 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.34 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16093019 | 0.94 | GLP1R (0.41) | GLP1RTLR2ALBC3AR1SIRT2 | |
| SCHEMBL16093009 | 0.92 | GLP1R (0.38) | GLP1RTLR2ALBC3AR1SIRT2 | |
| SCHEMBL25664162 | 0.90 | GLP1R (0.43) | GLP1RTLR2ALBCCKARCCKBR | |
| SCHEMBL14685801 | 0.87 | GLP1R (0.48) | GLP1RTLR2ALBCCKARCCKBR | |
| SCHEMBL17903320 | 0.87 | GLP1R (0.41) | GLP1RALBCCKARCCKBRC3AR1 | |
| SCHEMBL16093004 | 0.86 | GLP1R (0.37) | GLP1RTLR2ALBC3AR1SIRT2 | |
| SCHEMBL27310385 | 0.85 | GLP1R (0.57) | GLP1RTLR2ALBCCKARCCKBR | |
| SCHEMBL12972439 | 0.84 | GLP1R (0.61) | GLP1RTLR2CCKARCCKBR | |
| SCHEMBL19069621 | 0.82 | GLP1R (0.42) | GLP1RTLR2ALBC3AR1SIRT2 | |
| SCHEMBL8114033 | 0.82 | GLP1R (0.52) | GLP1RTLR2ALBCCKARCCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023069502-A2 | PEPTIDE CONJUGATES AND THERAPEUTIC AGENTS HAVING IMPROVED PHARMACOLOGICAL AND PHARMACOKINETIC PROPERTIES | RESOLUTE BIO, INC. (US) | 2023-04-27 | — | — | WO | disclosed |